Abstract
The susceptibility of 677 clinical bacterial isolates to temocillin was determined by broth microdilution and disk diffusion methods for the purpose of evaluating disks with three different temocillin concentrations and determining the temocillin disk diffusion interpretive criteria. The 60μg temocillin disk provided the highest interpretive accuracy (96.2 %), although the 30μg disk differed by having only three (1.2 %) additional minor interpretive errors. Based on available temocillin pharmacokinetics and recommended dosage schedules, the minimum inhibitory concentration breakpoints chosen were: ⩾ 32μg/ml = resistant and ⩽ 16μg/ml = susceptible. The corresponding disk diffusion zone diameter breakpoints for the 60μg disk were ⩽ 17 mm and ⩾ 21 mm; zone diameters of 18–20 mm were considered intermediate. For the 30μg disk these were ⩽ 15 mm, ⩾ 19 mm and 16–18 mm respectively.
Similar content being viewed by others
References
Fuchs, P. C., Barry, A. L., Jones, R. N., Thornsberry, C.: Temocillin: in vitro activity against 734 selected clinical isolates, including beta-lactamase-producing strains. Diagnostic Microbiology and Infectious Disease 1984, 2: 55–63.
Greenwood, D., Cowlishaw, A., Eley, A.: In vitro activity of temocillin. A new beta-lactamase-stable penicillin active againstEnterobacteriaceae. Antimicrobial Agents and Chemotherapy 1982, 22: 198–200.
Jules, K., Neu, H. C.: Antibacterial activity and betalactamase stability of temocillin. Antimicrobial Agents and Chemotherapy 1982, 22: 453–460.
Slocombe, B., Basker, M. J., Bentley, P. H., Clayton, J. P., Cole, M., Comber, K. R., Dixon, R. A., Edmondson, R. A., Jackson, D., Merrikin, D. S., Sutherland, R.: BRL 17421, a novel beta-lactam antibiotic, highly resistant to beta-lactamases, giving high and prolonged serum levels in humans. Antimicrobial Agents and Chemotherapy 1981, 20: 38–46.
Verbist, L.: In vitro activity of temocillin (BRL 17421), a novel beta-lactamase-stable penicillin. Antimicrobial Agents and Chemotherapy 1982, 22: 157–161.
Plot, P., Van Dyck, E.: In vitro activity of BRL 17421 againstHaemophilus influenzae, Neisseria gonorrhoeae, andBranhamella catarrhalis. Antimicrobial Agents and Chemotherapy 1982, 21: 166–167.
Yogev, R., Glogowski, W., Conner, E.: Comparative in vitro activity of temocillin (BRL 17421) and ampicillin againstHaemophilus influenzae type b. Antimicrobial Agents and Chemotherapy 1983, 23: 182–184.
National Committee for Clinical Laboratory Standards: Standard methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Tentative Standard M7-T. NCCLS, Villanova, PA, 1983.
National Committee for Clinical Laboratory Standards: Performance standards for antimicrobic disk susceptibility tests. Tentative Standard M2-T3. NCCLS, Villanova, PA, 1983.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fuchs, P.C., Barry, A.L., Thornsberry, C. et al. Interpretive criteria for temocillin disk diffusion susceptibility testing. Eur. J, Clin. Microbiol. 4, 30–33 (1985). https://doi.org/10.1007/BF02148656
Issue Date:
DOI: https://doi.org/10.1007/BF02148656